You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

CLINICAL TRIALS PROFILE FOR TRETINOIN MICROSPHERE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Tretinoin Microsphere

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00907257 ↗ A Study of Different Use Regimens Using Two Acne Treatments Completed Bausch Health Americas, Inc. Phase 4 2009-02-01 A study to determine if using 2 acne products in the morning is as safe and efficacious as using one product in the morning and one product in the evening.
NCT00907257 ↗ A Study of Different Use Regimens Using Two Acne Treatments Completed Valeant Pharmaceuticals International, Inc. Phase 4 2009-02-01 A study to determine if using 2 acne products in the morning is as safe and efficacious as using one product in the morning and one product in the evening.
NCT00939133 ↗ Proof of Concept Study to Investigate the Recurrence of Acne Post Isotretinoin Completed Johnson & Johnson Phase 4 2009-07-01 The use of topical retinoids is a mainstay and basis of early acne treatment to prevent the progression to inflammatory lesions. Post oral isotretinoin, it is not uncommon for non-inflammatory papules and comedones to recur. However, there has been no formal study to look at the prevention of recurrence of these acne lesions post isotretinoin in a long term basis. This may enhance the therapeutic options for post isotretinoin patients in order to prevent recurrence of their disease. Hypothesis Tretinoin microsphere 0.04% will prevent recurrence of acne lesions.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Tretinoin Microsphere

Condition Name

Condition Name for Tretinoin Microsphere
Intervention Trials
Acne 3
Acne Vulgaris 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Tretinoin Microsphere
Intervention Trials
Acne Vulgaris 3
Recurrence 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Tretinoin Microsphere

Trials by Country

Trials by Country for Tretinoin Microsphere
Location Trials
United States 14
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Tretinoin Microsphere
Location Trials
Texas 2
Florida 2
North Carolina 1
New Jersey 1
Virginia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Tretinoin Microsphere

Clinical Trial Phase

Clinical Trial Phase for Tretinoin Microsphere
Clinical Trial Phase Trials
Phase 4 3
Phase 3 2
Early Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Tretinoin Microsphere
Clinical Trial Phase Trials
Completed 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Tretinoin Microsphere

Sponsor Name

Sponsor Name for Tretinoin Microsphere
Sponsor Trials
Spear Pharmaceuticals 2
Bausch Health Americas, Inc. 1
Valeant Pharmaceuticals International, Inc. 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Tretinoin Microsphere
Sponsor Trials
Industry 7
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.